Sclerosis

MDPI AG

Journal websitePeer review: Other
Evaluation status available after sign-in

About the journal

Sclerosis is an open-access journal published by MDPI AG in Switzerland, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,000 CHF. Declared review time at DOAJ: 6 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
MDPI AG
ISSN
2813-3064
Country
Switzerland
Languages
english
Access
Open access
Declared publication charge
1,000 CHF
Articles in DOAJ
57
Declared review time
6 weeks
Declared peer-review model
other

Index listings

  • DOAJ · 2025-05-12
Indexing
DOAJ
APC
1,000 CHF
Declared review time (DOAJ)
6 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

57

Most recent article

4 months ago

Average review time (journal-declared via DOAJ)

6weeks

Works in OpenAlex

96

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

6

i10-index

2

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2025-05-12
Added to DOAJ
2025-05-12
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSS
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSS
Editorial board
Official page ↗
Open references deposited at Crossref
100%
ORCID iDs in current deposits
96%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity1
Source type
journal
Classification4

Subjects (DOAJ)

Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous systemMedicine: Dermatology

LCC codes

RC346-429RL1-803

Subject areas

  • Multiple Sclerosis Research Studies
  • Multiple Sclerosis Research Studies
  • Multiple Sclerosis Research Studies
  • Systemic Sclerosis and Related Diseases
  • Systemic Sclerosis and Related Diseases
  • Systemic Sclerosis and Related Diseases
  • Amyotrophic Lateral Sclerosis Research
  • Amyotrophic Lateral Sclerosis Research
Show all subjects (75)
  • Pulmonary Hypertension Research and Treatments
  • Connective tissue disorders research
  • Amyotrophic Lateral Sclerosis Research
  • Peripheral Neuropathies and Disorders
  • Peripheral Neuropathies and Disorders
  • Peripheral Neuropathies and Disorders
  • Balance, Gait, and Falls Prevention
  • Inflammatory Myopathies and Dermatomyositis
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Psoriasis: Treatment and Pathogenesis
  • Inflammatory Myopathies and Dermatomyositis
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Stroke Rehabilitation and Recovery
  • Connective Tissue Growth Factor Research
  • Chronic Kidney Disease and Diabetes
  • Connective Tissue Growth Factor Research
  • Polyomavirus and related diseases
  • Dementia and Cognitive Impairment Research
  • Systemic Lupus Erythematosus Research
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Long-Term Effects of COVID-19
  • Effects of Vibration on Health
  • Balance, Gait, and Falls Prevention
  • Renal Diseases and Glomerulopathies
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Effects of Vibration on Health
  • Long-Term Effects of COVID-19
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Systemic Lupus Erythematosus Research
  • Autoimmune Neurological Disorders and Treatments
  • Balance, Gait, and Falls Prevention
  • Chronic Kidney Disease and Diabetes
  • Skin Diseases and Diabetes
  • Autoimmune Neurological Disorders and Treatments
  • Renal Diseases and Glomerulopathies
  • Chronic Kidney Disease and Diabetes
  • Autoimmune Neurological Disorders and Treatments
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Renal Diseases and Glomerulopathies
  • Cancer-related cognitive impairment studies
  • Chronic Lymphocytic Leukemia Research
  • Neurological disorders and treatments
  • Systemic Lupus Erythematosus Research
  • Nutritional Studies and Diet
  • Cancer survivorship and care
  • Cancer Immunotherapy and Biomarkers
  • Hereditary Neurological Disorders
  • Mindfulness and Compassion Interventions
  • Neurological diseases and metabolism
  • Medical Practices and Rehabilitation
  • Neurological diseases and metabolism
  • Skin Diseases and Diabetes
  • MicroRNA in disease regulation
  • Olfactory and Sensory Function Studies
  • Genetic Neurodegenerative Diseases
  • Stroke Rehabilitation and Recovery
  • Genetic Neurodegenerative Diseases
  • COVID-19 and Mental Health
  • Dementia and Cognitive Impairment Research
  • Botulinum Toxin and Related Neurological Disorders
  • Mast cells and histamine
  • Stroke Rehabilitation and Recovery
  • Dementia and Cognitive Impairment Research
  • Olfactory and Sensory Function Studies
  • Botulinum Toxin and Related Neurological Disorders
  • COVID-19 and Mental Health

Keywords (DOAJ)

  • sclerosis
  • atherosclerosis

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: